原位杂化市场－全球产业规模、份额、趋势、机会和预测（按产品、技术、应用、最终用户、地区和竞争细分，2020-2030 年）

2024 年全球原位杂交 (ISH) 市值为 18.8 亿美元，预计到 2030 年将达到 29.1 亿美元，预测期内复合年增长率为 7.54%。由于 ISH 能够精确检测组织样本中的特定核酸序列，因此越来越被认为是分子诊断和生物医学研究中的重要工具。对疾病（尤其是肿瘤学和遗传疾病）的准确和早期检测的需求正在推动市场成长。 ISH 能够详细可视化基因表现模式和突变，使其成为个人化医疗策略的基石。

自动染色平台和高解析度成像等技术创新正在提高 ISH 的可用性和可靠性，促进其在临床实验室和研究机构的更广泛应用。多重检测和探针设计的改进使得同时检测多个基因目标成为可能，从而提高了诊断效率和患者预后。随着精准医疗的不断进步，ISH 在提供有针对性的治疗方案方面的相关性正在不断扩大，并加强了其在现代诊断和药物开发中的作用。

关键市场驱动因素

癌症和遗传疾病发生率上升

主要市场挑战

ISH技术和试剂成本高昂

主要市场趋势

与个人化医疗的整合

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球原位杂交市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按产品（仪器、耗材及配件、软体、服务）
  • 依技术分类（萤光原位杂交、显色原位杂交）
  • 依应用（癌症、细胞遗传学、传染病、神经科学、免疫学、其他）
  • 按最终用户（医院和诊断实验室、学术和研究机构、製药和生物技术公司、合约研究组织等）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美原位杂交市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲原位杂交市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太原位杂交市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲原位杂交市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东与非洲原位杂交市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Thermo Fisher Scientific, Inc.
• Abbott Laboratories Inc.
• PerkinElmer, Inc.
• Bio View Ltd.
• Agilent Technologies, Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Biotechne Corporation
• F. Hoffmann Roche AG
• Biocare Medical LLC

第 15 章：策略建议

第16章调查会社について・免责事项

The Global In Situ Hybridization (ISH) Market was valued at USD 1.88 Billion in 2024 and is projected to reach USD 2.91 Billion by 2030, growing at a CAGR of 7.54% during the forecast period. ISH is increasingly recognized as a vital tool in molecular diagnostics and biomedical research due to its capability to precisely detect specific nucleic acid sequences within tissue samples. The demand for accurate and early detection of diseases, particularly in oncology and genetic disorders, is driving market growth. ISH enables detailed visualization of gene expression patterns and mutations, making it a cornerstone in personalized medicine strategies.

Technological innovations such as automated staining platforms and high-resolution imaging are enhancing the usability and reliability of ISH, facilitating broader adoption in clinical laboratories and research institutions. Developments in multiplex assays and improved probe designs are enabling simultaneous detection of multiple genetic targets, improving diagnostic efficiency and patient outcomes. As precision medicine continues to advance, ISH's relevance in delivering targeted treatment options is expanding, strengthening its role in modern diagnostics and drug development.

Key Market Drivers

Rising Incidence of Cancer and Genetic Disorders

The increasing global burden of cancer and genetic diseases is a primary growth driver for the In Situ Hybridization market. According to the World Health Organization, cancer accounted for approximately 20 million new cases and 9.7 million deaths in 2022. Lung, breast, and colorectal cancers were among the most prevalent. These rising figures underscore the need for accurate molecular diagnostic tools that can provide specific and early detection. ISH, particularly Fluorescent In Situ Hybridization (FISH), plays a critical role in identifying genetic abnormalities, gene fusions, and chromosomal rearrangements within tissue samples, aiding in diagnosis, prognosis, and treatment planning.

Key Market Challenges

High Cost of ISH Technology and Reagents

The adoption of ISH techniques faces a significant hurdle due to the high costs associated with equipment and consumables. Advanced instruments such as hybridization systems and imaging platforms require substantial investment, which can be restrictive for smaller laboratories and facilities in developing regions. Additionally, reagents including specialized probes and buffers contribute to the overall expense, making frequent use of ISH less feasible in cost-sensitive healthcare environments. These cost barriers may limit the accessibility of high-precision diagnostics, particularly where budget constraints impact healthcare delivery.

Key Market Trends

Integration with Personalized Medicine

A notable trend shaping the ISH market is its growing integration into personalized medicine. ISH techniques, especially FISH, are being leveraged to detect genetic mutations and biomarkers that inform individualized treatment regimens. This alignment with precision healthcare is particularly prominent in oncology, where ISH supports targeted therapies by identifying specific molecular features of tumors. Companion diagnostics utilizing ISH allow clinicians to tailor treatments based on a patient's genetic profile, enhancing therapeutic efficacy and minimizing adverse effects. This synergy with precision medicine is reinforcing the value of ISH as a diagnostic standard in both clinical and research settings.

Key Market Players

• Thermo Fisher Scientific, Inc.
• Abbott Laboratories Inc.
• PerkinElmer, Inc.
• Bio View Ltd.
• Agilent Technologies, Inc.
• Merck KGaA
• Bio-Rad Laboratories, Inc.
• Biotechne Corporation
• F. Hoffmann Roche AG
• Biocare Medical LLC

Report Scope:

In this report, the Global In Situ Hybridization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

In Situ Hybridization Market, By Product:

• Instruments
• Consumables & Accessories
• Software
• Services

In Situ Hybridization Market, By Technology:

• Fluorescent In Situ Hybridization
• Chromogenic In Situ Hybridization

In Situ Hybridization Market, By Application:

• Cancer
• Cytogenetics
• Infectious Diseases
• Neuroscience
• Immunology
• Others

In Situ Hybridization Market, By End User:

• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Others

In Situ Hybridization Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global In Situ Hybridization Market.

Available Customizations:

Global In Situ Hybridization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global In Situ Hybridization Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Consumables & Accessories, Software, Services)
  • 5.2.2. By Technology (Fluorescent In Situ Hybridization, Chromogenic In Situ Hybridization)
  • 5.2.3. By Application (Cancer, Cytogenetics, Infectious Diseases, Neuroscience, Immunology, Others)
  • 5.2.4. By End User (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America In Situ Hybridization Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States In Situ Hybridization Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico In Situ Hybridization Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada In Situ Hybridization Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe In Situ Hybridization Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France In Situ Hybridization Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany In Situ Hybridization Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom In Situ Hybridization Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy In Situ Hybridization Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain In Situ Hybridization Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific In Situ Hybridization Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China In Situ Hybridization Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India In Situ Hybridization Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea In Situ Hybridization Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan In Situ Hybridization Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia In Situ Hybridization Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America In Situ Hybridization Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil In Situ Hybridization Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina In Situ Hybridization Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia In Situ Hybridization Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa In Situ Hybridization Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa In Situ Hybridization Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia In Situ Hybridization Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE In Situ Hybridization Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Thermo Fisher Scientific, Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Abbott Laboratories Inc.
• 14.3. PerkinElmer, Inc.
• 14.4. Bio View Ltd.
• 14.5. Agilent Technologies, Inc.
• 14.6. Merck KGaA
• 14.7. Bio-Rad Laboratories, Inc.
• 14.8. Biotechne Corporation
• 14.9. F. Hoffmann Roche AG
• 14.10. Biocare Medical LLC

15. Strategic Recommendations

16. About Us & Disclaimer